Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands.
BJU Int. 2018 Dec;122(6):978-985. doi: 10.1111/bju.14238. Epub 2018 Apr 27.
To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 classification systems for grade in T1 bladder cancer (T1-BC), as both are currently recommended in international guidelines.
Three uro-pathologists re-revised slides of 601 primary (first diagnosis) T1-BCs, initially managed conservatively (bacille Calmette-Guérin) in four hospitals. Grade was defined according to WHO1973 (Grade 1-3) and WHO2004 (low-grade [LG] and high-grade [HG]). This resulted in a lack of Grade 1 tumours, 188 (31%) Grade 2, and 413 (69%) Grade 3 tumours. There were 47 LG (8%) vs 554 (92%) HG tumours. We determined the prognostic value for progression-free survival (PFS) and cancer-specific survival (CSS) in Cox-regression models and corrected for age, sex, multiplicity, size and concomitant carcinoma in situ.
At a median follow-up of 5.9 years, 148 patients showed progression and 94 died from BC. The WHO1973 Grade 3 was negatively associated with PFS (hazard ratio [HR] 2.1) and CSS (HR 3.4), whilst WHO2004 grade was not prognostic. On multivariable analysis, WHO1973 grade was the only prognostic factor for progression (HR 2.0). Grade 3 tumours (HR 3.0), older age (HR 1.03) and tumour size >3 cm (HR 1.8) were all independently associated with worse CSS.
The WHO1973 classification system for grade has strong prognostic value in T1-BC, compared to the WHO2004 system. Our present results suggest that WHO1973 grade cannot be replaced by the WHO2004 classification in non-muscle-invasive BC guidelines.
比较世界卫生组织(WHO)1973 年和 2004 年分级系统在 T1 膀胱癌(T1-BC)中的预后价值,因为这两个系统目前都被国际指南推荐。
三位泌尿科病理学家重新审查了四家医院的 601 例原发性(首次诊断)T1-BC 的幻灯片,这些患者最初接受卡介苗保守治疗。根据 WHO1973 年(1-3 级)和 WHO2004 年(低级别[LG]和高级别[HG])标准定义分级。结果导致 1 级肿瘤缺乏,188 例(31%)为 2 级,413 例(69%)为 3 级肿瘤。LG 肿瘤有 47 例(8%),HG 肿瘤有 554 例(92%)。我们在 Cox 回归模型中确定了无进展生存(PFS)和癌症特异性生存(CSS)的预后价值,并校正了年龄、性别、多发性、大小和同时原位癌。
在中位随访 5.9 年后,148 例患者出现进展,94 例患者死于膀胱癌。WHO1973 分级 3 级与 PFS(风险比[HR]2.1)和 CSS(HR3.4)呈负相关,而 WHO2004 分级无预后意义。多变量分析显示,WHO1973 分级是进展的唯一预后因素(HR2.0)。3 级肿瘤(HR3.0)、年龄较大(HR1.03)和肿瘤大小>3cm(HR1.8)均与 CSS 较差独立相关。
与 WHO2004 分级系统相比,WHO1973 分级系统在 T1-BC 中具有较强的预后价值。我们目前的结果表明,在非肌肉浸润性膀胱癌指南中,WHO1973 分级不能被 WHO2004 分类取代。